Follow

Submissions from 2009

Assessment of junior faculty teaching skills and exposure to programs to help them learn how to teach, S. H. Fuller

Thromboembolic Disease, J. B. Groce

Basic statistics for residency projects, C. T. Herring

Drug-induced cardiovascular diseases, C. T. Herring

Hypertension in the elderly, C. T. Herring

Talking effectively with your pharmacist, C. T. Herring

Treatment options for the highly experienced HIV patient, K. E. Kelly

An academics specialty residency with combined internal medicine and infectious diseases clinical focus, D. B. May, R. H. Drew, and D. T. Wilson

Interpretation of common lab values, A. N. McLendon

Interpreting lab values: Using the numbers to guide patient care, A. N. McLendon

Women's health: Menopause and osteoporosis, A. N. McLendon

Pain management in the elderly, A. N. McLendon, H. Miriello, and T. Delgado

Submissions from 2008

Glucosamine sulfate/chondroitin sulfate; a joint effort; a combination worth consideration, R. Bloomfield, C. T. Herring, P. Stuart, K. Vaden, T. Smith, M. Hall-Spain, J. Varner, J. Rushing, and A. Weathers

Effect of pharmacists on medication errors in an emergency department, J. Brown, C. Barnes, V. E. Beasley, R. Cisneros, M. Pound, and C. T. Herring

Summer pre-health programs to engage underrepresented minorities, Financially disadvantaged & first generation college students (HPREP & SHPEP), K. J. Dunn, D. Ishem, C. Goode, D. Jackson, C. Vaske, and W. M. Moore

Boning up on osteoporosis, S. H. Fuller

Chantix in heavy vs. light smokers, S. H. Fuller

Establishing a TNT program, S. H. Fuller

Staying in the loop with lipids, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on lipid therapies, S. H. Fuller

Update on the treatment of rheumatoid arthritis, S. H. Fuller

Update on the treatment rheumatoid arthritis, S. H. Fuller

Health care system issues and implications for other drug classes, J. B. Groce

Link

Initial management of deep-venous thrombosis in the outpatient setting, J. B. Groce

Unfractionated heparin and low molecular weight heparin, J. B. Groce and J. E. Murphy

Basics for medical literature evaluation, C. T. Herring

Basic statistics for residency projects, C. T. Herring

Hypertension 2008, C. T. Herring

Pharmacy 101: Medical literature evaluation, C. T. Herring

Weighing in on the obesity epidemic: What pharmacists need to know, C. T. Herring

Rapid multifactorial endothelial dysfunction in DOCA-salt hypertension, R. H. Hilgers, B. Janssen, P. Lemkens, J. Nelissen, and Jo De Mey

Nursing home acquired Pneumonia, D. B. May

Common food-drug interactions, A. N. McLendon

Clinical case report: zinc supplementation, P. Stuart, R. Bloomfield, C. T. Herring, V. T. Sitaras, and R. C. David

Submissions from 2007

Link

Stress ulcer prophylaxis in hospitalized patients not in intensive care units, R. Arthur-Grube and D. B. May

Anti-Xa levels as a predictor of safety or efficacy in a community hospital, K. Corder and C. Zone

Link

Borderline Personality Disorder, J. D. Durham, R. R. Arthur Grube, and S. H. Fuller

A comparison of third year pharmacy students reading ability (NDRT) and PCAT scores, S. H. Fuller

FOG readability levels of required materials, S. H. Fuller

Staying in the loop with lipids, S. H. Fuller

Update on the treatment of rheumatoid arthritis, S. H. Fuller

Update on the treatment of rheumatoid arthritis, S. H. Fuller

Link

An assessment of pharmacy students' reading ability and the readability of required reading materials, S. H. Fuller, C. Horlen, B. Cisneros, and T. N. Merz

Mortality rates of patients treated with Drotrecogin alfa for severe Sepsis based on PROWESS eligibility, M. Goodwin, R. H. Drew, D. B. May, A. Scates, and E. Dodds-Ashley

Anticoagulation management strategies: Guide for the community pharmacist, J. B. Groce

Link

Improving the quality of care for venous thromboembolism and acute coronary syndrome : Using evidence-based guidelines and performance measures, J. B. Groce

Link

Translating evidence-based guidelines into performance measures for venous thromboembolism and acute coronary syndrome, J. B. Groce

Basic statistics for residency projects, C. T. Herring

Drug induced heart failure, C. T. Herring

Hypertension: 2007, C. T. Herring

Pitfalls of self medication for obesity, C. T. Herring

Talking effectively with your pharmacist, C. T. Herring

The obesity epidemic: What pharmacists need to know, C. T. Herring

Community pharmacy based clinical research: A primer on principles and practices, B. Jamerson and C. T. Herring

Vascular dementia, A. N. McLendon

Link

Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone, T. Merz and S. H. Fuller

Link

Clinical impact of selective serotonin reuptake inhibitor therapy with bleeding risks, M. S. Turner, D. B. May, R. A. Arthur, and G. Xiong

Submissions from 2006

PDF

Report of the AACP Criminal Background Check Advisory Panel, H. Anderson, M. A. Kirkpatrick, M. McKenzie, W. M. Moore, K. Williams, W. Wuller, E. Anagnostiadis, and L. Ross

Identifying the Presence of Peripheral Artery Disease in Patients without Diabetes, L. Brown and C. T. Herring

The treatment of rheumatoid arthritis, S. H. Fuller

The treatment of rheumatoid arthritis, S. H. Fuller

The treatment of rheumatoid arthritis, S. H. Fuller

The treatment of rheumatoid arthritis, S. H. Fuller

The treatment of rheumatoid arthritis, S. H. Fuller

The treatment of rheumatoid arthritis, S. H. Fuller

Basics for medical literature evaluation, C. T. Herring

Pitfalls of self medication for obesity, C. T. Herring

Talking effectively with your pharmacist, C. T. Herring

Decongestant use in hypertension, C. T. Herring, K. Maryansky, K. Trivette, and N. Hemberg

Clinical relevance and application of laboratory values, D. B. May

New options for varicella prophylaxis, D. B. May

Evaluation of reduction in polypharmacy in a long-term care population, A. N. McLendon

Overview of delirium, sundowning and insomnia treatment in the elderly, A. N. McLendon

Risk factors associated with Clostridium difficile - associated Diarrhea, M. S. Turner, K. S. Kaye, D. B. May, R. H. Drew, and E. Dodds Ashley

Submissions from 2005

The efficacy of statin therapy in relation to administration, S. H. Fuller

The treatment of dyslipidemias, S. H. Fuller

Treatment of dyslipidemias, S. H. Fuller

Update on the treatment of depression, S. H. Fuller

Update on the treatment of dyslipidemias, S. H. Fuller

Impact of the Modification in Renal Disease (MDRD) Equation on Antibiotic Dosing, W. J. Gibbs, D. B. May, E. D. Ashley, and R. D. Drew

2005 ACC/AHA heart failure guidelines, C. T. Herring

Basics for medical literature evaluation, C. T. Herring

Cardiovascular diseases medication management: Hypertension, C. T. Herring

Statistics overview: Basic statistics question and answer session, C. T. Herring

How do you treat hospital-acquired Pneumonia, D. B. May

Methods to estimate Creatinine clearance - The Cockcroft-Gault Equation, D. B. May

Mild cognitive impairment and cholinesterase inhibitors, A. N. McLendon

Link

Pharmacotherapy for human immunodeficiency virus-associated nephropathy, S. D. Pope, M. D. Johnson, and D. B. May

Link

Proposed mechanisms and preventative options of jarisch-herxheimer reactions, M. W. Pound and D. B. May

Link

Pharmacoeconomics and community practice, C. E. Reeder, J. P. Gagnon, and W. M. Moore

Link

The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients, N. Seshadri, S. Z. Goldhaber, U. Elkayam, R. A. Grimm, J. B. Groce, J. A. Heit, S. A. Spinler, A G. Turpie, G. Bosker, and A. L. Klein

The clinical effectiveness initiative: A pharmacy analysis to improve outcomes and costs of drug therapy, F. R. Vogenberg, J. B. Groce, and P. Larratt